Related Experiment Video
Updated: Jun 17, 2026

06:41
Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
Published on: May 19, 2023
Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential
Patricia Benveniste1, Catherine Frelin, Salima Janmohamed
1Ontario Cancer Institute, Toronto, ON M5G 2M9, Canada.
Cell Stem Cell
|January 16, 2010
Summary
Hematopoietic stem cells (HSCs) have a newly identified intermediate-term stage. These cells sustain clones for months, suggesting differentiation involves losing self-renewal stabilization, not capacity.
Area of Science:
- Hematology
- Stem Cell Biology
- Developmental Biology
Background:
- Sustained blood cell production relies on hematopoietic stem cells (HSCs) self-renewal and differentiation.
- Previously, only short-term (4-6 weeks) and long-term (lifelong) HSC self-renewal stages were recognized.
- The initial differentiation step's impact on self-renewal capacity remained unclear.
Purpose of the Study:
- To investigate the existence and characteristics of intermediate-term multipotent HSCs.
- To determine the self-renewal capabilities and clone persistence of these intermediate cells.
- To elucidate the mechanisms underlying the initial stages of HSC differentiation.
Main Methods:
- Utilized mouse models to study HSC differentiation and clone persistence.
- Employed techniques to separate and analyze distinct HSC populations based on self-renewal duration.
- Quantified clone persistence over extended periods (6-8 months).
Main Results:
- Identified a numerically dominant intermediate-term HSC population in mice.
- Demonstrated that these intermediate-term HSC clones persist for 6-8 months before extinction.
- Showed these cells are distinct from short-term and long-term HSCs.
- Found evidence that initial differentiation involves loss of self-renewal stabilization, not capacity.
Conclusions:
- A distinct intermediate-term HSC stage exists, bridging short-term and long-term self-renewal.
- HSC differentiation initiates with a loss of mechanisms stabilizing self-renewal across divisions.
- This finding refines our understanding of stem cell hierarchies and differentiation commitment.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

